Search Results
Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Chang Gung University, Taoyuan, Taiwan
Search for other papers by Yu-Ling Lu in
Google Scholar
PubMed
Search for other papers by Yu-Tung Huang in
Google Scholar
PubMed
Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Chang Gung University, Taoyuan, Taiwan
Search for other papers by Ming-Hsien Wu in
Google Scholar
PubMed
Search for other papers by Ting-Chao Chou in
Google Scholar
PubMed
Search for other papers by Richard J Wong in
Google Scholar
PubMed
Department of Internal Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan
Chang Gung University, Taoyuan, Taiwan
Search for other papers by Shu-Fu Lin in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is a rare disease with an incidence of 1–2 per million people per year. ATC is classified as stage IV disease and is one of the most lethal cancers with a median survival of 3–5 months upon
Endocrine Oncology Branch, Geisel School of Medicine at Dartmouth, National Institutes of Health, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Search for other papers by Amit Mehta in
Google Scholar
PubMed
Search for other papers by Lisa Zhang in
Google Scholar
PubMed
Search for other papers by Myriem Boufraqech in
Google Scholar
PubMed
Search for other papers by Yaqin Zhang in
Google Scholar
PubMed
Search for other papers by Dhaval Patel in
Google Scholar
PubMed
Search for other papers by Min Shen in
Google Scholar
PubMed
Search for other papers by Electron Kebebew in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common endocrine malignancy ( Howlader et al . 2013 ). Anaplastic thyroid cancer (ATC) accounts for 1–2% of all thyroid cancers, but is the most common cause of thyroid-cancer-related deaths ( Kebebew et al
Search for other papers by Francesca Marano in
Google Scholar
PubMed
Search for other papers by Roberto Frairia in
Google Scholar
PubMed
Search for other papers by Letizia Rinella in
Google Scholar
PubMed
Search for other papers by Monica Argenziano in
Google Scholar
PubMed
Search for other papers by Benedetta Bussolati in
Google Scholar
PubMed
Search for other papers by Cristina Grange in
Google Scholar
PubMed
Search for other papers by Raffaella Mastrocola in
Google Scholar
PubMed
Search for other papers by Isabella Castellano in
Google Scholar
PubMed
Search for other papers by Laura Berta in
Google Scholar
PubMed
Search for other papers by Roberta Cavalli in
Google Scholar
PubMed
Search for other papers by Maria Graziella Catalano in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is one of the most lethal cancers, its median survival being only 5 months, and 1-year survival being less than 20% ( Smallridge & Copland 2010 ). To date, a standard therapy for ATC does not exist
Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, University of Florence, Florence, Italy
Search for other papers by Clotilde Sparano in
Google Scholar
PubMed
Search for other papers by Yann Godbert in
Google Scholar
PubMed
Search for other papers by Marie Attard in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Slimane Zerdoud in
Google Scholar
PubMed
Search for other papers by Nathalie Roudaut in
Google Scholar
PubMed
Search for other papers by Charlotte Joly in
Google Scholar
PubMed
Search for other papers by Amandine Berdelou in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Livia Lamartina in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is a rare aggressive thyroid malignancy, with a median overall survival (OS) rate of only 5 months and a 1-year survival rate <20% ( Smallridge et al. 2012 ). In the absence of initial distant
Search for other papers by Xumeng Wang in
Google Scholar
PubMed
Search for other papers by Tianxing Ying in
Google Scholar
PubMed
Search for other papers by Jimeng Yuan in
Google Scholar
PubMed
Search for other papers by Yue Wang in
Google Scholar
PubMed
Search for other papers by Xingyun Su in
Google Scholar
PubMed
Search for other papers by Shitu Chen in
Google Scholar
PubMed
Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, China
Search for other papers by Yurong Zhao in
Google Scholar
PubMed
Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, China
Search for other papers by Yuanyuan Zhao in
Google Scholar
PubMed
Institute of Environmental Medicine of Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China
Search for other papers by Jinghao Sheng in
Google Scholar
PubMed
Search for other papers by Lisong Teng in
Google Scholar
PubMed
Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, China
Search for other papers by Chi Luo in
Google Scholar
PubMed
Search for other papers by Weibin Wang in
Google Scholar
PubMed
statistically significant at P < 0.05 and highly significant at P < 0.01. Data were analyzed using GraphPad Prism 8. Results Warburg effect promotes global lactylation in anaplastic thyroid cancer Lysine lactylation (La) is a newly discovered
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
Search for other papers by Kyungmin Lee in
Google Scholar
PubMed
Search for other papers by Sang-Hyun Lee in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Wooil Kim in
Google Scholar
PubMed
Search for other papers by Jangwook Lee in
Google Scholar
PubMed
Search for other papers by Jong-Gil Park in
Google Scholar
PubMed
Search for other papers by Jang-Seong Kim in
Google Scholar
PubMed
Search for other papers by Jung Tae Kim in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Minho Shong in
Google Scholar
PubMed
Search for other papers by Hyo Jin Lee in
Google Scholar
PubMed
Search for other papers by Jin-Man Kim in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Daejeon Endo Internal Medicine, Daejeon, Republic of Korea
Search for other papers by Koon Soon Kim in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Jeong-Ki Min in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is one of the most aggressive and lethal thyroid carcinomas. Although it accounts for <1–2% of all thyroid cancers ( Hundahl et al. 1998 ), its associated mortality is high owing to uncontrolled
Search for other papers by Xuguang Zhu in
Google Scholar
PubMed
Search for other papers by Sunmi Park in
Google Scholar
PubMed
Search for other papers by Woo Kyung Lee in
Google Scholar
PubMed
Search for other papers by Sheue-yann Cheng in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is one of the most aggressive endocrine malignancies. Patients rarely survive more than 1 year after diagnosis and have very limited treatment options. In addition to genetic alterations, aberrant
Search for other papers by Xuguang Zhu in
Google Scholar
PubMed
Search for other papers by Li Zhao in
Google Scholar
PubMed
Search for other papers by Woo Kyung Lee Doolittle in
Google Scholar
PubMed
Search for other papers by Sheue-yann Cheng in
Google Scholar
PubMed
Introduction Anaplastic thyroid cancer (ATC) is one of the most aggressive solid cancers in humans. ATC is usually resistant to conventional radioactive iodine therapy or chemotherapy. At the time of diagnosis, most ATC patients are ineligible
Search for other papers by Robert C Smallridge in
Google Scholar
PubMed
Search for other papers by Laura A Marlow in
Google Scholar
PubMed
Search for other papers by John A Copland in
Google Scholar
PubMed
, Rocha et al . (2003) evaluated 17 poorly differentiated (but no anaplastic) thyroid cancers. They found loss of cadherin 1, type 1, E-cadherin (epithelial) membrane expression, but no nuclear localization of catenin (cadherin-associated protein), beta
Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Jiajun Wu in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Juyong Liang in
Google Scholar
PubMed
Search for other papers by Ruiqi Liu in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Tian Lv in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Kangyin Fu in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Liehao Jiang in
Google Scholar
PubMed
Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Wenli Ma in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Yan Pan in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Zhuo Tan in
Google Scholar
PubMed
Search for other papers by Qing Liu in
Google Scholar
PubMed
Search for other papers by Weihua Qiu in
Google Scholar
PubMed
Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People’s Republic of China
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Search for other papers by Minghua Ge in
Google Scholar
PubMed
Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Clinical Research Center for Cancer of Zhejiang Province, Hangzhou, Zhejiang, People’s Republic of China
Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, China
Search for other papers by Jiafeng Wang in
Google Scholar
PubMed
. (D) and (E) Images and quantifications of TUNEL assay and IHC staining of Ki67, P62, LC3B, HO-1, and GPX4. (F) Schematic of anlotinib-mediated autophagy-ferroptosis signaling in anaplastic thyroid cancer. Tumorigenic markers were assayed by